Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 4743-4744 [2014-01630]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 19 / Wednesday, January 29, 2014 / Notices
Potential Commercial Applications:
• Diagnostic biomarker of DHF
• Point-of-care diagnostic testing
• Enzyme-linked immunosorbent
assay (ELISA) for clinical and laboratory
use
Competitive Advantages:
• While there are commerciallyavailable ELISAs to detect vitronectin,
these products have not been used for
dengue diagnosis
• Vitronectin assessment assays
provide a novel, specific biomarker for
the DHF disease state
• Easily developed for serologic
diagnostic assays
Development Stage:
• Pre-clinical
• In vitro data available
Inventors: Elizabeth Hunsperger
(CDC), Momar Ndao (McGill
University), Kay Tomashek (CDC), Betty
Poole-Smith (CDC)
Publication: Poole-Smith BK, et al.
Discovery and Validation of Prognostic
Biomarkers for Severe Dengue by
Proteomic Screening. International
Conference on Emerging Infectious
Diseases 2012: poster and oral
presentation abstracts. Emerg Infect Dis.
2012 Mar. [https://wwwnc.cdc.gov/eid/
pdfs/ICEID2012.pdf ]
Intellectual Property: HHS Reference
No. E–147–2013/0—
• PCT Application No. PCT/US2012/
025472 filed 16 Feb 2012, which
published as WO 2013/130029 on 06
Sep 2013
• US Patent Application No. 13/
985,507 filed 14 Aug 2013
Licensing Contact: Whitney Blair, J.D.,
M.P.H.; 301–435–4937; whitney.blair@
nih.gov.
tkelley on DSK3SPTVN1PROD with NOTICES
Real-Time RT–PCR Assay for Detection
of Noroviruses
Description of Technology: A specific
and sensitive TaqMan-based real-time
(rt) RT–PCR assay has been developed
by CDC scientists for detection of
noroviruses in clinical and
environmental specimens. This assay
can be implemented to rapidly detect
and distinguish norovirus strains from
genogroups I and II, which are
responsible for the majority of human
infections. Additionally, the assay is
multiplexed with an internal extraction
control virus (coliphage MS2) to
validate the results of the assay. Since
the virus cannot be grown in cell culture
and enzyme immunoassays lack the
necessary sensitivity, this technology is
particularly useful.
Potential Commercial Applications:
• Development of norovirus
diagnostics
• Specific rtRT–PCR assay for
detecting and distinguishing of the
VerDate Mar<15>2010
16:05 Jan 28, 2014
Jkt 232001
major pathogenic norovirus genogroups
(I and II) within clinical and
environmental samples
Competitive Advantages:
• This is an internally controlled,
multiplexed assay capable of rapid,
accurate identification of norovirus
genogroups responsible for human
illness
• Superior sensitivity compared with
immunoassay detection methods
Development Stage:
• Pre-clinical
• In vitro data available
Inventors: Jan Vinje, Nicole
Gregoricus, Preeti Chhabra, Leslie
Barclay, Hannah Shirley, David Lee (all
of CDC)
Publications:
1. Vega E, et al. Novel surveillance
network for norovirus gastroenteritis
outbreaks, United States. Emerg Infect
Dis. 2011 Aug;17(8):1389–95. [PMID
21801614]
2. Schultz AC, et al. Development and
evaluation of novel one-step TaqMan
realtime RT–PCR assays for the
detection and direct genotyping of
genogroup I and II noroviruses. J Clin
Virol. 2011 Mar;50(3):230–4. [PMID
21195660]
Intellectual Property: HHS Reference
No. E–145–2013/0—PCT Application
No. PCT/US2012/065269 filed 15 Nov
2012, which published as WO 2013/
074785 on 23 May 2013
Licensing Contact: Whitney Blair, J.D.,
M.P.H.; 301–435–4937; whitney.blair@
nih.gov.
Dated: January 23, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–01635 Filed 1–28–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The concept review and
the discussions could disclose
confidential trade secrets or commercial
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
4743
property such as patentable material,
and personal information concerning
individuals associated with the concept
review, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Fetal Body
Composition and Volumes in the NICHD
Fetal Growth Studies.
Date: February 12, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate concept
review.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680, skandasa@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: January 23, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01632 Filed 1–28–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development;
Special Emphasis Panel.
Date: February 3, 2014.
E:\FR\FM\29JAN1.SGM
29JAN1
tkelley on DSK3SPTVN1PROD with NOTICES
4744
Federal Register / Vol. 79, No. 19 / Wednesday, January 29, 2014 / Notices
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, National Institute of Child
Health And Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–451–3415, duperes@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Alexander disease;
Mechanisms, Modifiers and Therapeutics.
Date: February 7, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Administrator,
Scientific Review Branch, National Institute
of Child Health and Human Development,
6100 Executive Boulevard, Room 5B01,
Bethesda, MD 20892–9304, (301) 435–6680,
skandasa@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Health, Behavior, and Context
Subcommittee.
Date: February 17–18, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michele C. HindiAlexander, Ph.D., Division of Scientific
Review, National Institutes of Health, Eunice
Kennedy Shriver, National Institute for Child
Health & Development, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20812–7510, (301) 435–8382, hindialm@
mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: March 5, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Nichd, DSR, 6100 Executive Blvd.,
Bethesda, MD 20892, 301–435–6902,
PETER.ZELAZOWSKI@NIH.GOV.
Name of Committee: National Institute of
Child Health and Human Development Initial
VerDate Mar<15>2010
18:28 Jan 28, 2014
Jkt 232001
Review Group; Developmental Biology
Subcommittee.
Date: February 27, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW., Washington, DC
20036.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, DHHS, 6100 Executive
Blvd., Room 5B01–G, Bethesda, MD 20892,
301–435–6878, wedeenc@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Reproduction, Andrology,
and Gynecology Subcommittee.
Date: March 3, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington, DC/Rockville
Hotel, Rockville, MD 20852.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Administrator,
Scientific Review Branch, National Institute
of Child Health and Human Development,
NIH, 6100 Executive Boulevard, Room 5B01,
Bethesda, MD 20892, (301) 435–2717,
leszczyd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: January 23, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01630 Filed 1–28–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Interventional
studies of non-pharmacological management
of pain in military personnel (R01, R34).
Date: March 31–April 1, 2014.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Downtown Bethesda,
7335 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Hungyi Shau, Ph.D.,
Scientific review officer, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracty Boulevard, Suite 401, Bethesda,
MD 20892, 301–402–1030, Hungyi.Shau@
nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Health Services and
Observations of Non-Pharmacological
Management of Pain In Military Personnel
(R01).
Date: April 1, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Downtown Bethesda,
7335 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Hungyi Shau, Ph.D.,
Scientific Review Officer, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracty Boulevard, Suite 401, Bethesda,
MD 20892, 301–402–1030, Hungyi.Shau@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS).
Dated: January 23, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–01633 Filed 1–28–14; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 79, Number 19 (Wednesday, January 29, 2014)]
[Notices]
[Pages 4743-4744]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01630]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development; Special Emphasis Panel.
Date: February 3, 2014.
[[Page 4744]]
Time: 10:00 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D., Chief, Scientific
Review Branch, Scientific Review Branch, National Institute of Child
Health And Human Development, NIH, 6100 Executive Blvd., Room 5B01,
Bethesda, MD 20892, 301-451-3415, duperes@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Alexander disease; Mechanisms,
Modifiers and Therapeutics.
Date: February 7, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review
Administrator, Scientific Review Branch, National Institute of Child
Health and Human Development, 6100 Executive Boulevard, Room 5B01,
Bethesda, MD 20892-9304, (301) 435-6680, skandasa@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Health, Behavior, and Context
Subcommittee.
Date: February 17-18, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michele C. Hindi-Alexander, Ph.D., Division of
Scientific Review, National Institutes of Health, Eunice Kennedy
Shriver, National Institute for Child Health & Development, 6100
Executive Boulevard, Room 5B01, Bethesda, MD 20812-7510, (301) 435-
8382, hindialm@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: March 5, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, National Institutes of Health, Nichd, DSR, 6100 Executive
Blvd., Bethesda, MD 20892, 301-435-6902, PETER.ZELAZOWSKI@NIH.GOV.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Developmental Biology
Subcommittee.
Date: February 27, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW.,
Washington, DC 20036.
Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, DHHS, 6100
Executive Blvd., Room 5B01-G, Bethesda, MD 20892, 301-435-6878,
wedeenc@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Reproduction, Andrology, and
Gynecology Subcommittee.
Date: March 3, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington, DC/Rockville Hotel, Rockville, MD
20852.
Contact Person: Dennis E. Leszczynski, Ph.D., Scientific Review
Administrator, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Boulevard, Room
5B01, Bethesda, MD 20892, (301) 435-2717, leszczyd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: January 23, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-01630 Filed 1-28-14; 8:45 am]
BILLING CODE 4140-01-P
